Results 151 to 160 of about 3,454 (177)
Some of the next articles are maybe not open access.
Intravitreal Dexamethasone Implant in Vitreoretinal Surgery: An Overview of the Literature
Graefe's Archive for Clinical and Experimental OphthalmologyThe sustained-release intravitreal 0.7 mg dexamethasone implant (DEX implant) (Ozurdex®, Allergan®, an AbbVie Company, North Chicago, Illinois, USA) is widely used to treat various inflammatory retinal disorders. Notably, its application is expanding in the field of vitreoretinal surgery.We conducted a comprehensive literature search across the Web of ...
Boscia G. +15 more
openaire +2 more sources
Macular Hole Closure With Intravitreal Dexamethasone Implant
Ophthalmic Surgery, Lasers and Imaging Retina, 2023Arsalan A, Ali, Ashkan M, Abbey
openaire +2 more sources
Failure of intravitreal dexamethasone implant application
2020Intravitreal dexamethasone implantation (IVDI) has been introduced for indications of retinal venous occlusion, diabetic maculopathy and macular edema due to posterior uveitis. A 65-year-old man, who developed bilateral diabetic macular edema and had limited response to bilateral intravitreal anti-vascular endothelial growth factor injections, was ...
Aras, Ferişte, Ulas, Fatih
openaire +1 more source
Re: Intravitreal dexamethasone implant fragmentation
Canadian Journal of Ophthalmology, 2013Javier, Cabrerizo +1 more
openaire +2 more sources
Dexamethasone Intravitreal Implant During Phacoemulsification
Ophthalmology, 2013Aniruddha, Agarwal +3 more
openaire +2 more sources
Dexamethasone biodegradable intravitreal implant
2013David Callanan, Robert Wang
openaire +1 more source